1-[(aminooxy)methyl]-2-methoxynaphthalene | 178366-51-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-[(aminooxy)methyl]-2-methoxynaphthalene
• 英文别名: O-[(2-methoxynaphth-1-yl)methyl]hydroxylamine；O-[(2-methoxynaphthalen-1-yl)methyl]hydroxylamine
• CAS: 178366-51-3
• 化学式: C₁₂H₁₃NO₂
• 分子量: 203.241
• InChiKey: ATVXKDGCMAGAHJ-UHFFFAOYSA-N

物化性质

• 沸点：
  380.5±25.0 °C(Predicted)
• 密度：
  1.168±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  O-[(7-methoxynaphth-1-yl)methyl]-N-acetylhydroxylamine 、 1-[(aminooxy)methyl]-2-methoxynaphthalene 生成 O-[(2-methoxynaphth-1-yl)methyl]-N-acetylhydroxylamine
  参考文献：
  名称：

  O-arylmethyl-N-(thio)acylhydroxylamines

  摘要：

  本发明涉及从式（I）所示化合物中选择的化合物：##STR1## 其中Ar，X，R.sub.1和R.sub.2的定义如描述中所定义，并且含有这种化合物的药物制剂，用于治疗褪黑素系统的障碍。

  公开号：

  US05612368A1
• 作为产物：
  描述：

  1-(氯甲基)-2-甲氧基萘 在 sodium acetate 、 肼 作用下， 以 乙醇 、 二甲基亚砜 为溶剂， 反应 1.0h， 生成 1-[(aminooxy)methyl]-2-methoxynaphthalene
  参考文献：
  名称：

  Synthesis of new arylalkoxy amido derivatives as melatoninergic ligands

  摘要：

  Amido derivatives 10-18 of the corresponding oxyamines were synthesised as melatoninergic ligands by the reaction of hydroxyphtalimide with the halogeno derivatives or the corresponding alcohols using Mitsunobu reaction conditions. The affinity of the compounds for chicken brain melatonin receptors and recombinant human MT1 and MT2 receptors was evaluated using 2-[I-125]-iodomelatonin as the radioligand. Overall, the introduction of an oxygen atom in the amido chain was not a favourable parameter as the compounds were less potent than the corresponding deoxy derivatives. However, nanomolar compounds were obtained with the arylethyloxy derivatives (13c (R' = nPr), chicken brain, hMT(1), hMT(2), K-i values: 4.8, 3.86, 2.4 nM, respectively) and the 2,7-dimethoxynaphthalene derivatives (17c (R' = nPr), chicken brain, hMT(1), hMT(2), K-i values: 0.04, 0.13, 0.1 nM, respectively). The functional activity of these compounds was evaluated by the aggregation of melanophores in Xenopus laevis tadpoles and the potency was related to the affinity of the molecules for melatonin receptors. The compounds were found to be full agonists and compound 17a was 20-fold more potent than melatonin in this bioassay. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(02)00328-0

文献信息

• O-arylméthyl N-(thio)acyl hydroxylamines comme ligands des récepteurs de la mélatonine, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
  申请人：ADIR ET COMPAGNIE

  公开号：EP0709371B1

  公开（公告）日：1998-05-06
• US5612368A
  申请人：——

  公开号：US5612368A

  公开（公告）日：1997-03-18
• Synthesis of new arylalkoxy amido derivatives as melatoninergic ligands
  作者：Cécile Pégurier、Laurence Morellato、Eminn Chahed、Jean Andrieux、Jean-Paul Nicolas、Jean A Boutin、Caroline Bennejean、Philippe Delagrange、Michel Langlois、Monique Mathé-Allainmat

  DOI：10.1016/s0968-0896(02)00328-0

  日期：2003.3

  Amido derivatives 10-18 of the corresponding oxyamines were synthesised as melatoninergic ligands by the reaction of hydroxyphtalimide with the halogeno derivatives or the corresponding alcohols using Mitsunobu reaction conditions. The affinity of the compounds for chicken brain melatonin receptors and recombinant human MT1 and MT2 receptors was evaluated using 2-[I-125]-iodomelatonin as the radioligand. Overall, the introduction of an oxygen atom in the amido chain was not a favourable parameter as the compounds were less potent than the corresponding deoxy derivatives. However, nanomolar compounds were obtained with the arylethyloxy derivatives (13c (R' = nPr), chicken brain, hMT(1), hMT(2), K-i values: 4.8, 3.86, 2.4 nM, respectively) and the 2,7-dimethoxynaphthalene derivatives (17c (R' = nPr), chicken brain, hMT(1), hMT(2), K-i values: 0.04, 0.13, 0.1 nM, respectively). The functional activity of these compounds was evaluated by the aggregation of melanophores in Xenopus laevis tadpoles and the potency was related to the affinity of the molecules for melatonin receptors. The compounds were found to be full agonists and compound 17a was 20-fold more potent than melatonin in this bioassay. (C) 2002 Elsevier Science Ltd. All rights reserved.
• O-arylmethyl-N-(thio)acylhydroxylamines
  申请人：Adir et Compagnie

  公开号：US05612368A1

  公开（公告）日：1997-03-18

  The invention relates to a compound selected from those of formula (I): ##STR1## in which Ar, X, R.sub.1 and R.sub.2 are as defined in the description and a medicinal product containing the same in order to treat a disorder of the melatoninergic system.

  本发明涉及从式（I）所示化合物中选择的化合物：##STR1## 其中Ar，X，R.sub.1和R.sub.2的定义如描述中所定义，并且含有这种化合物的药物制剂，用于治疗褪黑素系统的障碍。